Drug
AZD1386 clinical trials
Also written AZD1386.
- studies test it
- 11
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
- AZD1386
- 11
Studies by the year they started
11 studies that test it; most in 2008 (6)
| Year | Studies |
|---|---|
| 2008 | 6 |
| 2009 | 5 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses AZD1386 is read from its arms, and is right about nine times in ten.
Testing it · 11
- Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD)CompletedPhase 2AstraZenecaNCT01019928Written as AZD1386
- Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386CompletedPhase 2AstraZenecaNCT00672646Written as AZD1386
- Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the KneeTerminatedPhase 2AstraZenecaNCT00878501Written as AZD1386
- Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386CompletedPhase 1AstraZenecaNCT00690079Written as AZD1386
- Formulation and Food Effect Study of AZD1386 in Healthy VolunteersCompletedPhase 1AstraZenecaNCT00714337Written as AZD1386
- Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy VolunteersTerminatedPhase 1AstraZenecaNCT00945178Written as AZD1386
- Study to Evaluate Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Peripheral Neuropathic PainTerminatedPhase 2AstraZenecaNCT00976534Written as AZD1386
- AZD1386 Japanese Multiple Ascending Dosing StudyCompletedPhase 1AstraZenecaNCT00736658Written as AZD1386
- Esophageal Hypersensitivity Study in Healthy VolunteersCompletedPhase 1AstraZenecaNCT00711048Written as AZD1386
- Investigation of Rate+Extent of Excretion of Radioactivity in Urine+Faeces After Oral Administration of [14C]AZD1386CompletedPhase 1AstraZenecaNCT00832169Written as AZD1386
- Study to Investigate the Effects Single Oral Dose of AZD1386 (Capsaicin)CompletedPhase 1AstraZenecaNCT00692146Written as AZD1386